COVID-19 Response: CMS Issues FAQs to Assist Medicare Providers
The agency is receiving questions from providers and created this document to be transparent and share answers to some of the most common questions.
Read MoreSearch Results for: liver disease
Mesa Biotech Developing Molecular Point-of-Care Diagnostic Test for COVID-19
Building upon the existing Accula molecular platform, Mesa’s coronavirus test aims to deliver accurate and accessible testing close to the patient, providing critical information to healthcare providers in China, the United States, and other affected countries
Read MoreCOVID-19 a Reminder of the Challenge of Emerging Infectious Diseases
Given the apparent efficiency of virus transmission, everyone should be prepared for COVID-19 to gain a foothold throughout the world, including in the United States.
Read MoreArcherDx and Illumina Partner to Comarket In Vitro Diagnostics
The comarketing partnership is intended to drive awareness of ArcherDx diagnostic products and increase access to vital genomic information in community oncology care settings.
Read More
Bioaster and Mologic Share Grant to Develop Rapid Diagnostic for Onchocerciasis
The Bill and Melinda Gates Foundation has granted the partners $885,000 to develop an advanced rapid diagnostic for onchocerciasis.
Read More